Telangiectasis: Clinical Trials

4 trials for Telangiectasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 unknown. 4 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Unknown 4
Phase 11Unknown 1

Follow Telangiectasis: new trials by email Literature Review of Telangiectasis trials Research Report on Telangiectasis

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pazopanib for the Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia
Pazopanib - Hereditary Hemorrhagic Telangiectasia, Epistaxis
Phase 1 / Phase 2UnknownCure HHT302023-07-012022-09-08
MBM-01 (Tempol) for the Treatment of Ataxia Telangiectasia
MBM-01 - Ataxia Telangiectasia Louis-Bar, Ataxia Telangiectasia in Children
Phase 2UnknownMatrix Biomed, Inc.202021-07-012021-05-17
Vitamin D and Hereditary Haemorrhagic Telangiectasia
Vit D, Placebo Oral Tablet - Hereditary Haemorrhagic Telangiectasia
Phase 2UnknownSt. Paul's Hospital, Canada602018-07-162019-06-11
Octreotide in Patients With GI Bleeding Due to Rendu-Osler-Weber
Octreotide LAR - Hereditary Hemorrhagic Telangiectasia, Gastrointestinal Hemorrhage
Phase 2UnknownRadboud University Medical Center152016-10-012018-04-20

Narrower conditions

Telangiectasia, Hereditary Hemorrhagic (3)  ·  Epistaxis (2)  ·  Anemia (1)  ·  Ataxia Telangiectasia (1)  ·  Gastrointestinal Hemorrhage (1)

Broader conditions

Cardiovascular Diseases (4)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4)  ·  Vascular Diseases (4)  ·  Cardiovascular Abnormalities (3)  ·  Congenital Abnormalities (3)  ·  Hematologic Diseases (3)  ·  Hemic and Lymphatic Diseases (3)  ·  Hemorrhage (3)  ·  Hemorrhagic Disorders (3)  ·  Hemostatic Disorders (3)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Vascular Malformations (3)  ·  Nose Diseases (2)

Interventions

Octreotide (1)  ·  pazopanib (1)  ·  tempol (1)

Sponsors

Cure HHT (1)  ·  Matrix Biomed, Inc. (1)  ·  Radboud University Medical Center (1)  ·  St. Paul's Hospital, Canada (1)

Countries

Canada (1)  ·  Netherlands (1)  ·  United States (1)

Top investigators

Joost Drenth, MD PhD (1)  ·  Raj Kasthuri, MD (1)